[Item 87--Mucocutaneous bacterial and fungal infections: Candida albicans]

MeSH terms

• Administration, Oral
• Administration, Topical
• Antifungal Agents / administration & dosage
• Antifungal Agents / therapeutic use
• Candidiasis* / diagnosis
• Candidiasis* / drug therapy
• Candidiasis* / prevention & control
• Candidiasis, Chronic Mucocutaneous / diagnosis
• Candidiasis, Chronic Mucocutaneous / drug therapy
• Candidiasis, Chronic Mucocutaneous / prevention & control
• Candidiasis, Cutaneous / congenital
• Candidiasis, Cutaneous / diagnosis
• Candidiasis, Cutaneous / drug therapy
• Candidiasis, Cutaneous / prevention & control
• Candidiasis, Oral / diagnosis
• Candidiasis, Oral / drug therapy
• Candidiasis, Oral / prevention & control
• Candidiasis, Vulvovaginal / diagnosis
• Candidiasis, Vulvovaginal / drug therapy
• Candidiasis, Vulvovaginal / prevention & control
• Dermatitis, Contact / diagnosis
• Diagnosis, Differential
• Female
• Humans
• Infant, Newborn
• Intertrigo / diagnosis
• Intertrigo / drug therapy
• Intertrigo / microbiology
• Male
• Onychomycosis / diagnosis
• Onychomycosis / drug therapy
• Pregnancy
• Pregnancy Complications, Infectious / diagnosis
• Pregnancy Complications, Infectious / drug therapy
• Psoriasis / diagnosis
• Secondary Prevention